European Journal of Surgical OncologyVolume 47, Issue 5, May 2021, Pages e300-e301P018. Use of magtrace® outside its licensing period to safeguard breast cancer patients during the COVID pandemic does not reduce efficacyAuthor links open overlay panelMoiz Qureshi, Nirmala Paramanathan, Kevin Harris, Rosie Stanton, Anne Stebbing, Natalie Chand, Natalia Robson, Siobhan LawsShow moreShareCitehttps://doi.org/10.1016/j.ejso.2021.03.022Get rights and contentReferences (0)Cited by (0)View full textCopyright © 2021 Published by Elsevier Ltd.